Scarica l'app Stockscreener
84.81
0.24%
0.20
Dopo l'orario di chiusura:
84.81
Precedente Chiudi:
$84.61
Aprire:
$84.72
Volume 24 ore:
1.80M
Relative Volume:
1.36
Capitalizzazione di mercato:
$11.51B
Reddito:
$2.94B
Utile/perdita netta:
$537.87M
Rapporto P/E:
21.56
EPS:
3.9341
Flusso di cassa netto:
$579.02M
1 W Prestazione:
+10.66%
1M Prestazione:
-10.73%
6M Prestazione:
-1.41%
1 anno Prestazione:
+44.73%
Intervallo 1D:
$84.16
$86.02
Intervallo di 1 settimana:
$76.52
$86.02
Portata 52W:
$51.79
$101.40
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Compare GMED vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
84.81 | 11.49B | 2.94B | 537.87M | 579.02M | 3.9341 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Aggiornamento | Needham | Hold → Buy |
| 2026-01-27 | Iniziato | TD Cowen | Buy |
| 2025-11-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-11-07 | Aggiornamento | Truist | Hold → Buy |
| 2025-10-28 | Ripresa | Stifel | Hold |
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $103 to $117 - Moomoo
Globus Medical, Inc. (GMED) Stock Report: Analyzing a 30.98% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Globus Medical’s SWOT analysis: stock gains momentum on spine growth By Investing.com - Investing.com Canada
Globus Medical’s SWOT analysis: stock gains momentum on spine growth - Investing.com
At US$84.61, Is It Time To Put Globus Medical, Inc. (NYSE:GMED) On Your Watch List? - 富途牛牛
Is It Time To Reassess Globus Medical (GMED) After Recent Share Price Swings? - Sahm
Zacks Industry Outlook Highlights Electromed, Globus Medical and Intuitive Surgical - Zacks Investment Research
Globus Medical Uses Generative AI And M&A To Reshape Growth Profile - Yahoo Finance
GMED Stock Price, Quote & Chart | GLOBUS MEDICAL INCA (NYSE:GMED) - ChartMill
3 Medical Instrument Stocks Exploring GenAI to Tackle Industry Woes - TradingView
Globus Medical Inc (GMED) Shares Surge 5.1% -- What GF Score of 97 Tells Investors - GuruFocus
Jim Cramer on Globus Medical: “There Is Not a Lot of Money to Be Made in This One” - Insider Monkey
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term - Yahoo Finance
Bull of the Day: Globus Medical (GMED) - The Globe and Mail
Globus Medical and Conagra Brands have been highlighted as Zacks Bull and Bear of the Day - Zacks Investment Research
Globus Medical IncA (NYSE:GMED) Passes Navellier's Little Book Screen - ChartMill
Globus Medical stock price target lowered to $87 by Freedom Broker - Investing.com UK
Needham Raises its Price Target on Globus Medical (GMED) - Insider Monkey
Globus Medical Q1 earnings call highlights - MSN
5 Must-Read Analyst Questions From Globus Medical’s Q1 Earnings Call - Yahoo Finance
Citizens reiterates Globus Medical stock rating after Q1 beat By Investing.com - Investing.com Canada
Globus Medical, Inc. (GMED) Investor Outlook: Exploring a 45.49% Potential Upside Amid Strong Revenue Growth - DirectorsTalk Interviews
Globus Medical, Inc. $GMED Shares Acquired by Northwestern Mutual Wealth Management Co. - MarketBeat
Is Reaffirmed 2026 Guidance and Capital Allocation Shifting the Investment Case for Globus Medical (GMED)? - Sahm
VIRGINIA RETIREMENT SYSTEMS ET Al Sells 17,300 Shares of Globus Medical, Inc. $GMED - MarketBeat
Globus Medical (GMED) Valuation Check After Share Price Drop And Solid Quarterly Results - Sahm
GMED Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Intramedullary Nail Leg Lengthening Market Size, & Report 2033 - UnivDatos
Globus Medical tanks 8% despite beating estimates for top and bottom lines - MSN
8-Day Sell-Off Sends Globus Medical Stock Down -17% - Trefis
Globus Medical Stock Slides 17% With A 8-Day Losing Spree - Trefis
Globus Medical Stock In Shambles: Down 17% With 7-Day Losing Streak - Trefis
7-Day Sell-Off Sends Globus Medical Stock Down -17% - Trefis
Canaccord Genuity maintains Globus Medical (GMED) buy recommendation - MSN
Stifel Nicolaus Reaffirms Their Hold Rating on Globus Medical (GMED) - The Globe and Mail
Research Alert: CFRA Keeps Hold Opinion On Shares Of Globus Medical Inc. - Moomoo
Globus Medical (GMED) Valuation Check After Strong Q1 2026 Earnings Beat And Raised Guidance - Yahoo Finance
3 Reasons Why Growth Investors Shouldn't Overlook Globus Medical (GMED) - sharewise.com
Down 13.8% in 4 Weeks, Here's Why You Should You Buy the Dip in Globus Medical (GMED) - Yahoo Finance
Is It Time To Reassess Globus Medical (GMED) After The Recent Share Price Pullback - Yahoo Finance
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.22%
1.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):